PT  - JOURNAL ARTICLE
AU  - Christopher G Jacob
AU  - Nguyen Thuy-Nhien
AU  - Mayfong Mayxay
AU  - Richard J Maude
AU  - Huynh Hong Quang
AU  - Bouasy Hongvanthong
AU  - Viengxay Vanisaveth
AU  - Thang Ngo Duc
AU  - Huy Rekol
AU  - Rob W van der Pluijm
AU  - Lorenz Von Seidlein
AU  - Rick M Fairhurst
AU  - Francois H Nosten
AU  - Md Amir Hossain
AU  - Naomi Park
AU  - Scott Goodwin
AU  - Pascal Ringwald
AU  - Keobouphaphone Chindavongsa
AU  - Paul N Newton
AU  - Elizabeth A Ashley
AU  - Sonexay Phalivong
AU  - Rapeephan R Maude
AU  - Rithea Leang
AU  - Cheah Huch
AU  - Le Thanh Dong
AU  - Kim-Tuyen Nguyen
AU  - Tran Minh Nhat
AU  - Tran Tinh Hien
AU  - Hoa Nguyen
AU  - Nicole Zdrojewski
AU  - Sara E Canavati
AU  - Abdullah A Sayeed
AU  - Didar Uddin
AU  - Caroline Buckee
AU  - Caterina I Fanello
AU  - Marie Onyamboko
AU  - Thomas Peto
AU  - Rupam Tripura
AU  - Chanaki Amaratunga
AU  - Aung Myint Thu
AU  - Gilles Delmas
AU  - Jordi Landier
AU  - Nguyen Hoang Chau
AU  - Dysoley Lek
AU  - Seila Suon
AU  - James J Callery
AU  - Podjanee Jittamala
AU  - Borimas Hanboonkunupakarn
AU  - Sasithon Pukrittayakamee
AU  - Aung Pyae Phyo
AU  - Frank Smithuis
AU  - Khin Lin
AU  - Myo Thant
AU  - Tin Maung Hlaing
AU  - Parthasarathi Satpathi
AU  - Sanghamitra Satpathi
AU  - Prativa K Behera
AU  - Amar Tripura
AU  - Subrata Baidya
AU  - Neena Valecha
AU  - Anupkumar R Anvikar
AU  - Akhter ul Islam
AU  - Abul Faiz
AU  - Chanon Kunasol
AU  - Eleanor Drury
AU  - Mihir Kekre
AU  - Mozam Ali
AU  - Katie Love
AU  - Shavanthi Rajatileka
AU  - Anna E Jeffreys
AU  - Kate Rowlands
AU  - Christina S Hubbart
AU  - Mehul Dhorda
AU  - Ranitha Vongpromek
AU  - Namfon Kotanan
AU  - Phrutsamon Wongnak
AU  - Jacob Almagro Garcia
AU  - Richard D Pearson
AU  - Cristina V Ariani
AU  - Thanat Chookajorn
AU  - Cinzia Malangone
AU  - T Nguyen
AU  - Jim Stalker
AU  - Ben Jeffery
AU  - Jonathan Keatley
AU  - Kimberly Johnson
AU  - Dawn Muddyman
AU  - Xin Hui S Chan
AU  - John Sillitoe
AU  - Roberto Amato
AU  - Victoria Simpson
AU  - Sonia Gonçalves
AU  - Kirk Rockett
AU  - Nicholas P Day
AU  - Arjen M Dondorp
AU  - Dominic P Kwiatkowski
AU  - Olivo Miotto
TI  - Genetic surveillance in the Greater Mekong Subregion and South Asia to support malaria control and elimination
AID  - 10.1101/2020.07.23.20159624
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.07.23.20159624
4099  - http://medrxiv.org/content/early/2020/07/25/2020.07.23.20159624.short
4100  - http://medrxiv.org/content/early/2020/07/25/2020.07.23.20159624.full
AB  - The use of parasite genetic data by National Malaria Control Programmes (NMCPs) is currently limited, and typically focused on specific genetic features or a small number of study sites. We have developed GenRe-Mekong, a platform for genetic surveillance of malaria in the Greater Mekong Subregion (GMS). By integrating simple sample collection procedures in the routine operations of public health facilities, GenRe-Mekong enables NMCPs to conduct large-scale surveillance project in endemic regions. Samples are processed by the SpotMalaria platform, which uses high-throughput technologies to produce a broad set of genotypes, including most known drug resistance markers, species markers and a genomic barcode. Through the application of heuristics based on published evidence, GenRe-Mekong delivers Genetic Report Cards, a compendium of genotypes and phenotype predictions that are used to map prevalence of resistance to multiple drugs. To date, GenRe-Mekong has worked with NMCPs in five countries, and with several large-scale research projects, processing 9,645 samples from clinical cases. The monitoring of resistance markers has been especially valuable for NMCPs tracking the recent rapid spread of DHA-piperaquine resistant parasites across the region. In Vietnam and Laos, data from GenRe-Mekong have provided novel knowledge about the spread of these resistant strains in provinces previously thought to be unaffected. GenRe-Mekong facilitates data sharing by aggregating at regional level results from different countries, providing cross-border views of the spread of resistant strains.Competing Interest StatementThe authors have declared no competing interest.Funding StatementBill & Melinda Gates Foundation, Wellcome Trust, UK Medical Research Council, UK Department for International Development, NIAIDAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Oxford Tropical Research Ethics Committee, Oxford, UK; Ethical Committee, Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam; Ministry of Health National Ethics Committee For Health Research, Laos; Ethics Committee, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand; National Ethics Committee for Health Research, Ministry of Health, Phnom Penh, Cambodia; Ethics Review Committee on medical research involving human beings from Myanmar, Ministry of Health and Sports, Department of Medical Research (Lower Myanmar); Bangladesh Medical Research Council Ethical Committee; Comite d'Ethique, Ecole de Sante Publique, Universite de Kinshasa, Ministere de l'Enseignement Superieur, Universitaire et Recherche Scientifique, D. R. Congo; Harvard University Human Research Protection Program;All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll genotyping data and metadata is available from the manuscript's resource page. https://www.malariagen.net/resource/29